ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Packaging/Delivery System Integrity And Self-Sealing Capacity Of Vial Systems

  Review the scope and testing procedures required by General Chapter USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems.

• Maximize Global Regulatory Collaboration

  When marketing a combination product globally, pharmaceutical manufacturers and drug delivery technology providers must have a collaborative infrastructure based on strategic alignment, proactive regulatory awareness, lifecycle support, and continuous improvement globally.

• Design Success Combined With Expertise In Testing And Raw Material Selection

  Learn more about improvements and optimized benefits across the packaging attributes required for performance, quality, and safety of the packaging and delivery of lyophilized drug products.

• Navigating PFAS In Medical Devices

  Review how an experienced partner can help you navigate the shifting regulatory landscape for your medical device.

• 10 Ways To Align Your Medical Device With Human Factors Industry Best Practices

  Discover how patient-centric design principles can improve the development of medical devices. By focusing on user needs and behaviors, manufacturers can ensure that products align with expectations.

• Establishing And Safeguarding Shelf Life In Combination Products

  Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.

• Overcome Common Pre-Filled Syringe Challenges Through Partnership

  The pre-filled syringe space is one of the fastest growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled; there are particular obstacles to overcome.

• Age-Appropriate Pediatric Formulation Development

  There is a significant variability in the pharmacokinetics of the same drug and dosage form between pediatric and adult populations, and the factors impacting drug bioavailability are different in children.

• Accelerating The Development Of Oncology Medicines

  Oncology drug development has seen a significant shift in focus, as molecule chemistries and drug technologies have improved. Explore five areas for consideration and the potential emerging solutions.

• Partnering For Success In Sustained Drug Delivery Formulations

  With a focus on the sustained and controlled drug delivery segment of the pharmaceutical market, learn about technology platforms, support services, and sustainable solutions.